Sharma Nidhi, Garg Veena
Department of Bioscience and Biotechnology, Banasthali University, Banasthali, Rajasthan 304022, India.
Indian J Biochem Biophys. 2009 Feb;46(1):99-105.
The possible protective effect of ethanolic extract of B. monosperma leaves (BMEE) on diabetes and diabetes-induced oxidative stress was evaluated in alloxan (ALXN)-induced diabetic male adult mice. Experimental animals were divided into three groups viz., I, II, and III. Diabetes mellitus (DM) was induced in groups II and III mice by a single intraperitoneal injection of alloxan (150 mg/kg body wt). Group I (control mice) received an equal volume of normal saline. Group III mice were further treated with BMEE (300 mg/kg body wt, p.o.) for a period of 45 days. Body weight and fasting blood glucose (FBG) levels were measured at periodic intervals during the test period. At the end of treatment period, blood was collected by cardiac puncture under mild ether anesthesia and serum was isolated to analyze its lipid profile i.e. serum total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL), low density lipoprotein (LDL) and very low density lipoprotein (VLDL). The homogenates of hepatic, pancreatic and renal tissues were also analyzed for both enzymatic and non-enzymatic antioxidants, such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), reduced glutathione (GSH), thiobarbituric acid reactive substances (TBARS) and total protein (TP). Alloxan injection resulted in a significantly (P < 0.05) increased concentration of FBG level. Besides, the levels of enzymatic and nonenzymatic antioxidants were decreased and TBARS level increased significantly (P < 0.05) in hepatic, pancreatic and renal tissues. Also, serum TC, TG, LDL and VLDL-cholesterol level elevated significantly (P < 0.05), whereas HDL-cholesterol reduced significantly (P < 0.05) in group II (alloxan-treated diabetic control). The FBG level decreased significantly (P < 0.05) after 45 days treatment of BMEE from 172 to 117.143 mg/dl, as compared to normal control (79.286 mg/dl). The activities of antioxidant enzymes (CAT and GSH-Px) and GSH level in hepatic, pancreatic and renal tissues also increased significantly (P < 0.05) in BMEE-treated mice, but the activity of SOD was not improved significantly. BMEE treatment also reduced the TBARS levels and lowered serum lipid profile significantly (P < 0.05). The findings of the present study indicated significant hypoglycemic and anti-oxidant activity in B. monosperma leaves, thus lends credence to its folklore use in the management and/or control of type-2 DM.
在四氧嘧啶(ALXN)诱导的成年雄性糖尿病小鼠中,评估了单籽紫珠叶乙醇提取物(BMEE)对糖尿病及糖尿病诱导的氧化应激的潜在保护作用。实验动物分为三组,即I组、II组和III组。通过单次腹腔注射四氧嘧啶(150 mg/kg体重)诱导II组和III组小鼠患糖尿病。I组(对照小鼠)注射等体积的生理盐水。III组小鼠进一步用BMEE(300 mg/kg体重,口服)治疗45天。在试验期间定期测量体重和空腹血糖(FBG)水平。治疗期结束时,在轻度乙醚麻醉下通过心脏穿刺采集血液,分离血清以分析其血脂谱,即血清总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)和极低密度脂蛋白(VLDL)。还分析了肝、胰和肾组织匀浆中的酶促和非酶促抗氧化剂,如超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GSH-Px)、还原型谷胱甘肽(GSH)、硫代巴比妥酸反应物质(TBARS)和总蛋白(TP)。注射四氧嘧啶导致FBG水平显著(P < 0.05)升高。此外,肝、胰和肾组织中酶促和非酶促抗氧化剂水平降低,TBARS水平显著升高(P < 0.05)。而且,II组(四氧嘧啶处理的糖尿病对照组)血清TC、TG、LDL和VLDL胆固醇水平显著升高(P < 0.05),而HDL胆固醇显著降低(P < 0.05)。与正常对照组(79.286 mg/dl)相比,BMEE治疗45天后FBG水平从172显著降低(P < 0.05)至117.143 mg/dl。在接受BMEE治疗的小鼠中,肝、胰和肾组织中的抗氧化酶(CAT和GSH-Px)活性和GSH水平也显著升高(P < 0.05),但SOD活性没有显著改善。BMEE治疗还显著降低了TBARS水平并降低了血脂谱(P < 0.05)。本研究结果表明单籽紫珠叶具有显著的降血糖和抗氧化活性,因此证实了其在民间用于管理和/或控制2型糖尿病的用途。